<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Perpetual V(D)J recombinase activity involving multiple DNA double-strand break events in B-cell lineage <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells may introduce secondary genetic aberrations leading towards malignant progression </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we investigated defective negative feedback signaling through the (pre-) B-cell receptor as a possible reason for deregulated V(D)J recombinase activity in B-cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>On studying 28 cases of pre-B-lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> and 27 B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, expression of the (pre-) B-cell receptor-related linker molecule SLP65 (SH2 domain-containing lymphocyte protein of 65 kDa) was found to be defective in seven and five cases, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>SLP65 deficiency correlates with RAG1/2 expression and unremitting V(H) gene rearrangement activity </plain></SENT>
<SENT sid="4" pm="."><plain>Reconstitution of SLP65 expression in SLP65-deficient <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells results in downregulation of RAG1/2 expression and prevents both de novo V(H)-DJ(H) rearrangements and secondary V(H) replacement </plain></SENT>
<SENT sid="5" pm="."><plain>We conclude that iterative V(H) gene rearrangement represents a frequent feature in B-lymphoid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, which can be attributed to SLP65 deficiency in many cases </plain></SENT>
</text></document>